Le Clech, Alice <br/><br/>
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.  [electronic resource] 

 -  Kidney international  06 2019 
 - 1443-1452 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1755 
<br/><br/><label>Standard No.: </label>10.1016/j.kint.2019.01.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Atypical Hemolytic Uremic Syndrome--genetics<br/>Child<br/>Child, Preschool<br/>Complement Activation--genetics<br/>Complement Inactivating Agents--therapeutic use<br/>Complement System Proteins--genetics<br/>Disease Progression<br/>Female<br/>France--epidemiology<br/>Hemolytic-Uremic Syndrome--etiology<br/>Humans<br/>Kidney--immunology<br/>Kidney Failure, Chronic--epidemiology<br/>Male<br/>Middle Aged<br/>Plasmapheresis--statistics & numerical data<br/>Registries--statistics & numerical data<br/>Renal Dialysis--statistics & numerical data<br/>Renal Insufficiency, Chronic--epidemiology<br/>Retrospective Studies<br/>Risk Factors<br/>Treatment Outcome<br/>Young Adult